SPI PHARMACEUTICALS FUNDING MAJOR CHILDREN'S VACCINE CAMPAIGN IN THE BALKANS
SPI PHARMACEUTICALS FUNDING MAJOR CHILDREN'S
VACCINE CAMPAIGN IN THE BALKANS
COSTA MESA, Calif., June 24 /PRNewswire/ -- SPI Pharmaceuticals Inc. (AMEX: SPI) announced today it is assisting in funding a major emergency pediatric project for children in Kosovo, a region of Yugoslavia. Doctors are working to end an outbreak of polio and guard against other preventable childhood diseases.
The project is being undertaken by Doctors of the World, an American affiliate of Medecins du Monde, an international medical humanitarian organization. The organization is well-known for sending volunteer doctors and other health care professionals on missions of international medical assistance, including disaster relief. It is a non-profit, non-governmental humanitarian organization.
Children up to age 5 in the predominantly Albanian area are being inoculated against diphtheria, tetanus, whooping cough, measles, mumps, rubella and polio. There already is a polio epidemic in this region of 1.8 million people. A team of physicians from America, France, Greece and Czechoslovakia are expected to work six months on the project, which is also being funded by the Popper Foundation in Switzerland.
The physicians' group is planning a major medical education effort, including involving religious leaders, in stressing the importance of the vaccinations.
"This important campaign is being funded because of our compassion for the children, who are living through a very difficult time," says Milan Panic, chairman and chief executive officer of SPI and its parent company, ICN Pharmaceuticals Inc. SPI recently donated a large quantity of vitamins to nearby Bosnia-Herzegovina and has provided humanitarian medical aid to Russia, the Ukraine, Latin America, the Philippines and other nations.
Headquartered in Costa Mesa, SPI manufactures, markets and distributes 600 prescription and nonprescription pharmaceuticals in more than 60 countries. It has plants and facilities in North and Latin America and Western and Eastern Europe.
/CONTACT: Jack Sholl of SPI Pharmaceuticals, 714-545-0100, ext. 3013/
(SPI) CO: SPI Pharmaceuticals Inc. ST: California IN: MTC SU: KJ-EH -- LA007 -- 3117 06/24/92 08:06 EDT